SBC Medical Group Holdings Inc (SBC) Current Deferred Revenue (2023 - 2026)
SBC Medical Group Holdings' (SBC) quarterly Current Deferred Revenue came in at $5.4 million in Q4 2025, up 552.6% YoY from $820898.0 in Q4 2024, and up 419.91% on a QoQ basis from $1.0 million in Q3 2025.
SBC Medical Group Holdings Inc (SBC) Current Deferred Revenue (2023 - 2026) Analysis & Trends
SBC Medical Group Holdings (SBC) has 3 years of Current Deferred Revenue data on file, last reported at $5.4 million in Q4 2025.
- Quarterly Current Deferred Revenue rose 552.6% year-over-year to $5.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.4 million (up 552.6% YoY) and the FY2025 annual result came in at $5.4 million, up 552.6% from the prior year.
- Current Deferred Revenue grew to $5.4 million in Q4 2025, from $1.0 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $23.1 million in Q4 2023 to a low of $525497.0 in Q1 2025.
- A 3-year average of $6.0 million and a median of $1.0 million in 2025 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2024 — Current Deferred Revenue sank 96.44% — and 2025, when it surged 552.6%.
- Tracing SBC's Current Deferred Revenue over 3 years: stood at $23.1 million in 2023, then slumped by 96.44% to $820898.0 in 2024, then surged by 552.6% to $5.4 million in 2025.
- The last three Current Deferred Revenue figures came in at $5.4 million (Q4 2025), $1.0 million (Q3 2025), and $10.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.99 Mn |
| Dec 31, 2025 | 5.36 Mn |
| Sep 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | 10.33 Mn |
| Mar 31, 2025 | 525,497.00 |
| Dec 31, 2024 | 820,898.00 |
| Sep 30, 2024 | 565,495.00 |
| Dec 31, 2023 | 23.06 Mn |